A randomised 2 × 2 trial of community versus hospital pulmonary rehabilitation for chronic obstructive pulmonary disease followed by telephone or conventional follow-up

Health Technology Assessment

Volumn 14, Issue 6, 2010, Pages 1-164

  Waterhouse, J C ^a   Walters, S J ^b   Oluboyede, Y ^b   Lawson, R A ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BECLOMETASONE DIPROPIONATE; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CARBOCISTEINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FRUMIL; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; PREDNISOLONE; QUININE SULFATE; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMMUNITY BASED REHABILITATION; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DRUG COST; ENDURANCE; EXERCISE; FOLLOW UP; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HOSPITAL CARE; HUMAN; INTERMETHOD COMPARISON; KINESIOTHERAPY; PULMONARY REHABILITATION; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TELEPHONE; THERAPY EFFECT; TREATMENT OUTCOME; UNITED KINGDOM; WALKING;

EID: 77950538684     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta14060     Document Type: Article

References (57)

1. Chronic obstructive pulmonary disease: national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl. 1):1-232.
2. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;4:CD00379.
3. Goldstein RS, Gort EH, Stubbing D, Avendano MA, Guyatt GH. Randomised controlled trial of respiratory rehabilitation. Lancet 1994;344:1394-7.
4. California Pulmonary Rehabilitation Collaborative Group. Effects of pulmonary rehabilitation on dyspnea, quality of life, and healthcare costs in California. J Cardiopulm Rehabil 2004;24:52-62.
5. Karapolat H, Atasever A, Atamaz F, Kirazli Y, Elmas F, Erdinc E. Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation? Lung 2007;185:221-5.
6. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413.
7. Spruit MA, Troosters T, Trappenburg JC, Decramer M, Gosselink R. Exercise training during rehabilitation of patients with COPD: a current perspective. Patient Educ Couns 2004;52:243-8.
8. Schoo AM. A literature review of rehabilitative intervention for chronic obstructive pulmonary disease patients. Aust Health Rev 1997;20:120-32.
9. The Stationery Office. Our health, our care, our say: a new direction for community services. Norwich: Pbd TSO; 2006.
10. Foglio K, Bianchi L, Bruletti G, Porta R, Vitacca M, Balbi B, et al. Seven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programs. Respir Med 2007;101:1961-70.
11. Spencer LM, Alison JA, McKeough ZJ. Do supervised weekly exercise programs maintain functional exercise capacity and quality of life, twelve months after pulmonary rehabilitation in COPD? BMC Pulm Med 2007;7:7.
12. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-22.
13. Eaton T, Young P, Nicol K, Kolbe J. The endurance shuttle walking test: a responsive measure in pulmonary rehabilitation for COPD patients. Chron Respir Dis 2006;3:3-9.
14. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir Care 2001;46:798-825.
15. Fletcher CM, Elmes PC, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working populations. Br Med J 1959;1:257-66.
16. StataCorp. Stata Statistical Software: Release 9.0. College Station, Texas: Stata Corporation; 2005.
17. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials E9. Current Step 4 version dated 5 February 1998.
18. Morley JE. Undernutrition: Merck Manual Professional. URL: www.merck.com/mmpe/sec01/ch002/ch002a.html (accessed September 2009).
19. Moher D, Schulz KF, Altman DG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
20. Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.
21. Frison L, Pocock SJ. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med 1992;11:1685-704.
22. Diggle PJ, Heagerty P, Liang K-Y, Zeger SL. Analysis of longitudinal data. 2nd edition. Oxford: Oxford University Press; 2002.
23. Campbell MJ, Machin D, Walters SJ. Medical Statistics: A text book for the health sciences. 4th edition. Chichester: Wiley; 2007.
24. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Centre; 1993.
25. Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res 2005;14:1523-32.
26. National Institute for Clinical Excellence. Guide to the methods of technology appraisal. London: NICE; 2004.
27. Curtis L, Netten A. Unit costs of health and social care. University of Kent, PSSRU: Kent; 2005
28. Brazier JE, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
29. Claxton K. The irrelevance of inference: a decision making approach to the stochastic evaluation of health care technologies. J Health Econ 1999;18:341-64.
30. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd edition. Oxford: Oxford University Press; 2005.
31. Walters SJ. Consultants' forum: should post hoc sample size calculations be done? Pharm Stat 2009;8:163-9.
32. Elliott M, Watson C, Wilkinson E, Musk AW, Lake FR. Short-and long-term hospital and community exercise programmes for patients with chronic obstructive pulmonary disease. Respirology 2004;9:345-51.
33. Arnold E, Bruton A, Ellis-Hill C. Adherence to pulmonary rehabilitation: A qualitative study. Respir Med 2006;100:1716-23.
34. Taylor R, Dawson S, Roberts N, Sridhar M, Partridge MR. Why do patients decline to take part in a research project involving pulmonary rehabilitation? Respir Med 2007;101:1942-6.
35. Fischer MJ, Scharloo M, Abbink JJ, Thijs-Van A, Rudolphus A, Snoei L, et al. Participation and drop-out in pulmonary rehabilitation: a qualitative analysis of the patient's perspective. Clin Rehabil 2007;21:212-21.
36. Garrod R, Marshall J, Barley E, Jones PW. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J 2006;27:788-94.
37. O'Shea SD, Taylor NF, Paratz JD. But watch out for the weather: factors affecting adherence to progressive resistance exercise for persons with COPD. J Cardiopulm Rehabil Prev 2007;27:166-74.
38. Wuest J. Institutionalizing women's oppression: the inherent risk in health policy that fosters community participation. Health Care Women Int 1993;14:407-17.
39. Puhan MA, Guyatt GH, Goldstein R, Mador J, McKim D, Stahl E, et al. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other healthrelated quality of life instruments for patients with chronic lung disease. Respir Med 2007 Feb;101:308-16.
40. NICE. Pulmonary rehabilitation service for patients with COPD. URL: http://www.nice.org.uk/usingguidance/commissioningguides/pulmonaryrehabilitationserviceforpatientswithcopd/pulmonaryrehabilitationservicecopd.jsp (accessed September 2009).
41. Williams JE, Singh SJ, Sewell L, Morgan MD. Health status measurement: sensitivity of the self-reported Chronic Respiratory Questionnaire (CRQ-SR) in pulmonary rehabilitation. Thorax 2003;58:515-8.
42. Rutten-van Molken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 2006;130:1117-28.
43. Spruit MA, Troosters T, Trappenburg JC, Decramer M, Gosselink R. Exercise training during rehabilitation of patients with COPD: a current perspective. Patient Educ Couns 2004;52:243-8.
44. Karapolat H, Atasever A, Atamaz F, Kirazli Y, Elmas F, Erdinc E. Do the benefits gained using a short-term pulmonary rehabilitation program remain in COPD patients after participation? Lung 2007;185:221-5.
45. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000;355:362-8.
46. Troosters T, Gosselink R, Decramer M. Short-and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Am J Med 2000;109:207-212.
47. Strijbos JH, PostmaDS, van Altena R, Gimeno F, Koeter GH. A comparison between an outpatient hospital-based pulmonary rehabilitation program and a home-care pulmonary rehabilitation program in patients with COPD: a follow-up of 18 months. Chest 1996;109:366-372.
48. Engstrom CP, Persson LO, Larsson S, Sullivan M. Long-term effects of a pulmonary rehabilitation programme in outpatients with chronic obstructive pulmonary disease: a randomized controlled study. Scand J Rehabil Med 1999;31:207-13.
49. Foglio K, Bianchi L, Bruletti G, Battista L, Pagani M, Ambrosino N. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 1999;13:125-32.
50. Vale F, Reardon JZ, ZuWallack RL. The long-term benefits of outpatient pulmonary rehabilitation on exercise endurance and quality of life. Chest 1993;103:42-5.
51. Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med 2003 Mar;167:880-8.
52. Wewel AR, Gellerman I, Schwerfege I, Morfeld M, Magnussen H, Jorres RA. Intervention by phone calls raises domiciliary activity and exercise capacity in patients with severe COPD. Respir Med 2008;102:20-6.
53. Wijkstra PJ, van Altena R, Krann J, Otten V, Postma DS, Koeter GH. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax 1995;50:824-8.
54. Monninkhof E, van der Valk P, Schermer T, van der Palen J, van Herwaarden C, Zielhuis G. Economic evaluation of a comprehensive self-management programme in patients with moderate to severe chronic obstructive pulmonary disease. Chron Respir Dis 2004;1:7-16.
55. Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 2001;56:779-84.
56. Golmohammadi K, Jacobs P, Sin DD. Economic evaluation of a community-based pulmonary rehabilitation program for chronic obstructive pulmonary disease. Lung 2004;182:187-96.
57. Nonoyama ML, Brooks D, Lacasse Y, Guyatt GH, Goldstein RS. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007;2:CD005372.